Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karina Serban, MD
University of Florida, College of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Shands at the University of Florida
Gainesville, Florida, United States
Karina Serban, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Aug 2007
- Primary completion
- 20 Jul 2032
- Completion
- 20 Jul 2033
- Last update posted
- 6 Nov 2025
- Registered enrollment
- 220
- Registry id
- NCT01851642
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.